Merit Medical Systems (MMSI) Osake Kurssi
Merit Medical Systems Kurssi
Liikevaihto on kasvanut 11,5 % vuodessa viimeisten 19 vuoden aikana 1,51 Mrd. USD:een. Osakekohtainen tulos on kasvanut 10,0 % vuodessa viimeisten 19 vuoden aikana. Merit Medical Systemsn nettomarginaali on nyt 8,5 %, noussut 4,5 %:sta muutama vuosi sitten. Analyytikoiden mediaanitavoitehinta on 100,00 USD, eli yli nykyhintaa 15,6 %. 17 analyytikosta 14 suosittaa ostoa — kokonaiskonsensus on Osta.
Merit Medical Systems osakekurssi
Merit Medical Systems liiketoimintamalli ja osakeanalyysi
Usein kysytyt kysymykset Merit Medical Systems -osakkeesta
Merit Medical Systems Inc is a medical device company that focuses on designing, manufacturing, and distributing medical products to improve patient outcomes. Their business model involves developing and providing innovative and high-quality medical devices and accessories to healthcare professionals worldwide. Merit Medical systems Inc aims to enhance patient care and clinical outcomes through their comprehensive portfolio of products, which includes catheters, inflation devices, guide wires, and many other medical devices. Their commitment to research, development, and continuous innovation has made them a trusted name in the medical industry.
Merit Medical Systems Inc is primarily active in the healthcare industry.
The main competitors of Merit Medical Systems Inc in the market include Becton Dickinson and Company, Boston Scientific Corporation, Medtronic PLC, and Smiths Medical.
Merit Medical Systems Inc is a reputable company in the medical device industry. Established in 1987, Merit Medical specializes in developing and manufacturing innovative and high-quality medical devices to enhance patient outcomes worldwide. With a focus on interventional and diagnostic procedures, the company offers a broad range of products including catheters, syringes, drainage systems, and more. Merit Medical has grown significantly since its inception, expanding its global presence through strategic acquisitions and partnerships. Its commitment to delivering superior healthcare solutions has earned Merit Medical a strong reputation among healthcare professionals and patients alike.
Merit Medical Systems Inc has achieved several significant milestones throughout its history. Since its inception, the company has strived to provide innovative and high-quality medical products to healthcare professionals and patients globally. One notable milestone is the development and commercialization of the unique Merit Laureate® hydrophilic guide wire, which offers enhanced trackability and navigation during medical procedures. Additionally, Merit Medical Systems Inc has successfully expanded its product portfolio, introducing a wide range of state-of-the-art devices for cardiovascular, endoscopy, and interventional radiology procedures. The company's commitment to research and development, coupled with its dedication to improving patient outcomes, has solidified Merit Medical Systems Inc as a trusted leader in the medical device industry.
Merit Medical Systems Inc is primarily present in various countries and regions across the globe. As a leading healthcare company, Merit Medical Systems Inc operates in North America, Europe, Asia-Pacific, Latin America, and the Middle East. With a widespread presence, the company serves healthcare professionals and patients alike in these regions. Merit Medical Systems Inc's commitment to expanding its presence across diverse markets underscores its dedication to providing innovative medical devices and solutions internationally.
Merit Medical Systems Inc represents values and a corporate philosophy centered around patient care, innovation, integrity, and collaboration. As a leading global manufacturer and distributor of medical devices and supplies, Merit Medical Systems Inc prioritizes improving patient outcomes through the development of cutting-edge medical solutions. With a commitment to ethical business practices, the company strives to maintain the trust of healthcare professionals and patients alike. Merit Medical Systems Inc fosters a culture of innovation, leveraging expertise and partnerships to deliver advanced medical technologies. By placing emphasis on collaboration and teamwork, the company strives to continuously improve patient care and positively impact the healthcare industry.
Analyytikot asettavat tällä hetkellä Merit Medical Systems-osakkeelle keskimääräisen tavoitehinnan 99,22 USD (mediaani: 100,00 USD), mikä merkitsee +14,7 % viimeisimpään hintaan verrattuna. Konsensus perustuu 17 analyytikkoarvioon.
17 analyytikkoa arvioi tällä hetkellä Merit Medical Systems-osaketta: 14 suosittaa ostoa, 3 pitoa ja 0 myyntiä. Vuodelle 2026 analyytikot odottavat Merit Medical Systems-yhtiöltä 1,64 Mrd. USD liikevaihtoa ja 4,33 USD osakekohtaista tulosta.
Nykyisellä valuuttakurssilla Merit Medical Systems-osake noteerataan hintaan 77,22 EUR (86,54 USD).
Merit Medical Systems-osake (MMSI) on listattuna 3 pörssissä, muun muassa: NASDAQ (MMSI), Frankfurt (MM3.F), München (MM3.MU).
Merit Medical Systems Inc. is a US-based company that specializes in the development, manufacturing, and distribution of products for the diagnosis, treatment, and management of patients with critical medical needs. The company was founded in 1987 and works closely with physicians and healthcare professionals to develop innovative products that enable improved clinical efficiency and patient outcomes. Merit Medical Systems focuses on various areas such as interventional radiology, cardiology, endoscopy, dialysis, oncology, and infusion. Each area has its own unique range of products tailored to the specific needs of patients and healthcare professionals. In the field of interventional radiology, Merit Medical Systems offers a wide range of products such as catheters, guide wires, and stents for diagnostic and therapeutic purposes. This includes products like Embosphere Microspheres embolization particles for the treatment of liver tumors and the AceWire guide wire system. In cardiology, Merit Medical focuses on providing solutions for complex cardiac procedures including the treatment of congenital heart defects, vascular narrowing, or valve problems. One example is the Prelude Sheath Introducer system for transcatheter aortic valve implantation (TAVI), a minimally invasive alternative to open heart surgery. In the field of endoscopy, Merit Medical Systems offers a wide range of products for diagnostic and therapeutic purposes for the gastrointestinal tract system, such as the Bull's Horn Suprapubic Catheter for percutaneous kidney stone removal. In the field of dialysis, Merit Medical Systems' portfolio includes products for hemodialysis, peritoneal dialysis, and hemofiltration. One example is the Hero Graft for dialysis patients, which allows for long-lasting and secure vascular access maintenance. In oncology, Merit Medical focuses on interventions for tumors, such as the STAR Tumor Ablation System for the treatment of malignant liver tumors, the eIFU NanoKnife for the treatment of soft tissue tumors like the pancreas or lung. Another important segment of Merit Medical Systems is infusion, which includes a wide range of products such as catheters, ports, and infusion pumps for medication and fluid delivery. The Spectrum Catheter and Port system are notable in this area. Merit Medical Systems has an extensive network of sales partners and branches throughout North America, Europe, the Middle East, and Asia to deliver products to customers quickly and effectively. The company's business model is based on providing innovative, high-quality products along with excellent customer service and training to create value for customers. Merit Medical Systems follows a strategy of continuously increasing market share to enhance revenue growth and profitability. In summary, Merit Medical Systems is an innovative company specializing in the development, manufacturing, and distribution of products for critical medical applications. With a wide range of areas and products, the company focuses on continuous innovation, high quality, and excellent customer service to increase its market share and competitiveness.
odotettu liikevaihto Merit Medical Systems on 1,64 Mrd. USD. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.
odotettu voitto Merit Medical Systems on 260,14 M USD. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.
Merit Medical Systems:n hinta-voitto-suhde (P/E) on tällä hetkellä 19,97. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Merit Medical Systems-osakkeen arvostusta.
Merit Medical Systems:n hinta-myynti-suhde (P/S) on tällä hetkellä 3,17. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Merit Medical Systems-osakkeen arvostuskennuslukuna.
Merit Medical Systems:n Eulpool-laatuscore on 5/10.
Merit Medical Systems:n ISIN on US5898891040. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.
Merit Medical Systems:n WKN on 882361. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.
Merit Medical Systems:n ticker on MMSI. Tämä pörssinoteeraus käytetään Merit Medical Systems-osakkeiden kauppaan pörssissä.
Merit Medical Systems osake
Merit Medical Systems vertaisryhmä
Merit Medical Systems Ticker
Merit Medical Systems FIGI
Kaikki tunnusluvut ja syvällinen analyysi Merit Medical Systems:sta
Meidän osakeanalyysimme Merit Medical Systems-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut Merit Medical Systems:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: